{"title":"Correlation between DVH parameters and lung function changes before and after radiotherapy and the occurrence of radiation induced lung injury (RILI).","authors":"Sha Sha, Jigang Dong, Maoyu Wang, Ziyu Chen, Peng Gao","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the correlation between dose volume histogram (DVH) parameters and lung function changes before and after radiotherapy and the occurrence of radiation-induced lung injury (RILI), and to evaluate its value in predicting the risk of RILI.</p><p><strong>Methods: </strong>120 patients with advanced non-small cell lung cancer diagnosed in Jiaozhou Central Hospital of Qingdao City in the past three years and received chest conformal (intensity modulated) radiation therapy were selected. Before radiotherapy, irradiation of 45-50 Gy, and 1 month after radiotherapy, the patients were tested for lung function. The evaluation of radiation lung injury was based on the RTOG acute radiation lung injury classification standard, and the observation end point was ≥2 grade RILI.</p><p><strong>Results: </strong>There are 34 patients with ≥2 grade RILI among all enrolled patients, including 23 cases of grade 2 and 11 cases of grade 3. The difference between FVC, FEV1, FEV1 / FVC, DLCO, V5, V10, V15 before radiotherapy, 45-50 Gy, and 1 month after radiotherapy were statistically significant (P <0.05). The lung function, V5, V10, and V15 before radiotherapy were related factors for RILI (P <0.05). And the risk of RILI was 1.855 times that of patients with higher FEV1 / FVC before radiation therapy (OR = 1.855 (1.199-1.946)), patients with V10 ≥50% were 3.673 times higher than patients with V10 <50% (OR = 3.673(1.548-7.582)).</p><p><strong>Conclusions: </strong>V10≥50% and FEV1 / FVC are high-risk factors for RILI before radiotherapy, which has certain value in predicting the risk of RILI.</p>","PeriodicalId":19098,"journal":{"name":"Neuro endocrinology letters","volume":"42 5","pages":"297-304"},"PeriodicalIF":0.6000,"publicationDate":"2021-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro endocrinology letters","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To explore the correlation between dose volume histogram (DVH) parameters and lung function changes before and after radiotherapy and the occurrence of radiation-induced lung injury (RILI), and to evaluate its value in predicting the risk of RILI.
Methods: 120 patients with advanced non-small cell lung cancer diagnosed in Jiaozhou Central Hospital of Qingdao City in the past three years and received chest conformal (intensity modulated) radiation therapy were selected. Before radiotherapy, irradiation of 45-50 Gy, and 1 month after radiotherapy, the patients were tested for lung function. The evaluation of radiation lung injury was based on the RTOG acute radiation lung injury classification standard, and the observation end point was ≥2 grade RILI.
Results: There are 34 patients with ≥2 grade RILI among all enrolled patients, including 23 cases of grade 2 and 11 cases of grade 3. The difference between FVC, FEV1, FEV1 / FVC, DLCO, V5, V10, V15 before radiotherapy, 45-50 Gy, and 1 month after radiotherapy were statistically significant (P <0.05). The lung function, V5, V10, and V15 before radiotherapy were related factors for RILI (P <0.05). And the risk of RILI was 1.855 times that of patients with higher FEV1 / FVC before radiation therapy (OR = 1.855 (1.199-1.946)), patients with V10 ≥50% were 3.673 times higher than patients with V10 <50% (OR = 3.673(1.548-7.582)).
Conclusions: V10≥50% and FEV1 / FVC are high-risk factors for RILI before radiotherapy, which has certain value in predicting the risk of RILI.
期刊介绍:
Neuroendocrinology Letters is an international, peer-reviewed interdisciplinary journal covering the fields of Neuroendocrinology, Neuroscience, Neurophysiology, Neuropsychopharmacology, Psychoneuroimmunology, Reproductive Medicine, Chronobiology, Human Ethology and related fields for RAPID publication of Original Papers, Review Articles, State-of-the-art, Clinical Reports and other contributions from all the fields covered by Neuroendocrinology
Letters.
Papers from both basic research (methodology, molecular and cellular biology, anatomy, histology, biology, embryology, teratology, normal and pathological physiology, biophysics, pharmacology, pathology and experimental pathology, biochemistry, neurochemistry, enzymology, chronobiology, receptor studies, endocrinology, immunology and neuroimmunology, animal physiology, animal breeding and ethology, human ethology, psychology and others) and from clinical research (neurology, psychiatry and child psychiatry, obstetrics and gynecology, pediatrics, endocrinology, immunology, cardiovascular studies, internal medicine, oncology and others) will be considered.
The Journal publishes Original papers and Review Articles. Brief reports, Special Communications, proved they are based on adequate experimental evidence, Clinical Studies, Case Reports, Commentaries, Discussions, Letters to the Editor (correspondence column), Book Reviews, Congress Reports and other categories of articles (philosophy, art, social issues, medical and health policies, biomedical history, etc.) will be taken under consideration.